A detailed history of Kbc Group Nv transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 921 shares of TMDX stock, worth $74,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
921
Previous 921 -0.0%
Holding current value
$74,536
Previous $139,000 4.32%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$72.62 - $150.62 $11,183 - $23,195
154 Added 20.08%
921 $139,000
Q4 2023

Feb 13, 2024

BUY
$36.74 - $81.08 $28,179 - $62,188
767 New
767 $61,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.58B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.